| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 06/18/2008 | EP1232160B1 Spiro(2h-1-benzopyran-2,4'-piperidine)derivates as glycine transport inhibitors |
| 06/18/2008 | CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone |
| 06/17/2008 | US7388005 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 06/17/2008 | CA2467356C Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
| 06/17/2008 | CA2383114C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions |
| 06/12/2008 | WO2008067863A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 06/12/2008 | US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 06/12/2008 | US20080139575 Certain chemical entities, compositions, and methods |
| 06/12/2008 | US20080139567 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 06/12/2008 | US20080138353 Alpha b-chrystallin as a therapy for inflammation |
| 06/12/2008 | US20080138347 Dsp-10 dual-specificity phosphatase |
| 06/12/2008 | US20080138341 Anti-CD70 antibody and its use for the treatment of cancer and immune disorders |
| 06/12/2008 | US20080138333 Internalizing anti-cd74 antibodies and methods of use |
| 06/12/2008 | US20080138321 Method for enhancing stem cell trafficking |
| 06/11/2008 | EP1930439A1 Neurotrophic factors |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1368032B1 Excitatory amino acid receptor antagonists |
| 06/11/2008 | CN101194888A Drotaverin HCl freeze-dried powder needle injection and method for producing the same |
| 06/11/2008 | CN100393320C Oligonucleotide medicine for treating myophagism |
| 06/10/2008 | US7384963 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase |
| 06/10/2008 | US7384950 Respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384949 For therapy and prophylaxis of disorder in which the blocking of purine receptors, particularly adenosine receptors and more may be beneficial, such a Parkinson's disease or depression, cognitive or memory impairment, pain |
| 06/10/2008 | US7384784 Pax-encoding vector and use thereof |
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | CA2365826C Over-coated chewing gum formulations |
| 06/10/2008 | CA2288287C Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate |
| 06/05/2008 | WO2008067527A1 Inhibitors of protein tyrosine phosphatase for the treatment of muscle atrophy and related disorders |
| 06/05/2008 | WO2008066145A1 Thiazole derivative and use thereof as vap-1 inhibitor |
| 06/05/2008 | WO2008066117A1 Cyclic amine compound |
| 06/05/2008 | US20080132704 3-Substituted quinuclidines and their use |
| 06/05/2008 | US20080132548 Certain chemical entities, compositions, and methods |
| 06/05/2008 | US20080132545 Certain chemical entities, compositions, and methods |
| 06/05/2008 | US20080131416 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders |
| 06/05/2008 | US20080131410 Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| 06/05/2008 | US20080131407 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | CA2693178A1 Myostatin inhibition for enhancing muscle and/or improving muscle function |
| 06/05/2008 | CA2670976A1 Cyclic amine compound |
| 06/04/2008 | EP1927367A1 Novel pharmaceutical using anti-hla antibody |
| 06/04/2008 | EP1456357B1 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 06/04/2008 | CN101190196A Diazepam chewable tablets for dog or cat |
| 06/04/2008 | CN100391972C Corticotropin releasing factor receptor 2 agonists |
| 06/04/2008 | CN100391942C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing same and their use in medicaments |
| 06/04/2008 | CN100391534C Modulation of smooth muscle cell proliferation |
| 06/03/2008 | US7381790 Copolymers for suppression of autoimmune diseases, and methods of use |
| 06/03/2008 | US7381726 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 06/03/2008 | US7381699 Reagents and methods for smooth muscle therapies |
| 06/03/2008 | CA2339628C Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome |
| 06/03/2008 | CA2313024C Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/03/2008 | CA2263184C Methods and compositions for increasing the anaerobic working capacity in tissues |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2008009802A3 Drugs comprising an inhibitor of class 1 alpha mannosidase for the treatment of sarcoglycanopathies |
| 05/29/2008 | WO2007106884A3 Methods of treating muscular wasting diseases using nf-kb activation inhibitors |
| 05/29/2008 | US20080125491 screening for neuroprotectants such as -Isobutyryl-1,4-a-dimethyl-1,2,3,4,4a,9,10,10a-octahydro-phenanthrene-1-carboxylic acid amide, used for the prevention of neurodegenerative diseases and cardiovascular disorders |
| 05/29/2008 | US20080125419 Benzothiazole derivatives with activity as adenosine receptor ligands |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125399 N-[3-(trifluoromethyl)pyridin-2-yl]-4-methyl-6-methyl-3-oxo-4-aza-5 alpha -androst-5-en-17 beta -acetamide; useful for the treatment of conditions caused by androgen deficiency such as osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, cancer cachexia, Alzheimer's disease |
| 05/29/2008 | US20080125354 With triple helix and/or poly-proline type II transition state analog phosphorus based inhibitor comprising a phosphonamide, phosphinic peptide or phosphonate ester; e.g. (R,S)-2-Isopropyl-3-((1-(N-(9-Fluorenylmethoxycarbonyl)amino)-methyl)-adamantyloxyphosphinyl)propanoic acid; antitumor agents |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124399 Such as capsules/beads of cyclobenzaprine hydrochloride |
| 05/29/2008 | US20080124398 Modified release dosage forms of skeletal muscle relaxants |
| 05/28/2008 | EP1924592A2 Process for the synthesis of rocuronium bromide |
| 05/28/2008 | EP1924255A1 Use of n-(dibenz (b,f)oxepin-10-ylmethyl)-n-methyl-n-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | CN101189262A Humanin receptor or humanin-like polypeptide receptor |
| 05/28/2008 | CN101185762A Ciliary neurotrophic factors decorated by polyglycol polymer and preparation method thereof |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390131C Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 05/28/2008 | CN100389820C Therapeutic agent comprising botulinum neurotoxin |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378425 For preventing, treating and/or improving a disease against which a sigma receptor binding action and/or an acetylcholinesterase inhibitory action is efficacious |
| 05/27/2008 | US7378389 Neurotoxic component has been purified from a botulinum toxin by fermenting a Clostridium botulinum to botulinum toxin type A; promotion of normal muscle growth |
| 05/22/2008 | WO2008060051A1 Transnasal anticonvulsive pharmaceutical composition |
| 05/22/2008 | WO2008059959A1 Nerve elongation promoter and elongation inhibitor |
| 05/22/2008 | WO2008035001A3 Composition for the treatment of amyotrophic lateral sclerosis |
| 05/22/2008 | US20080119514 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases |
| 05/22/2008 | US20080119484 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 05/22/2008 | US20080119468 Phthalazine, aza-and diaza-phthalazine compounds and methods of use |
| 05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
| 05/22/2008 | US20080119386 Nutritional formula for athletes' recovery |
| 05/22/2008 | CA2678225A1 Transnasal anticonvulsive pharmaceutical composition |
| 05/22/2008 | CA2669800A1 Nerve elongation promoter and elongation inhibitor |
| 05/21/2008 | CN101181536A Chinese medicine for curing multiple pumping symptoms |
| 05/21/2008 | CN101181325A Korean ginseng extract and uses thereof |
| 05/20/2008 | US7375252 Compounds and method for the inhibition of the expression of VCAM-1 |
| 05/20/2008 | US7375215 Compounds for PDT |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2385440C 5-hydroxysapogenin derivatives with anti-dementia activity |
| 05/20/2008 | CA2385410C Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 05/20/2008 | CA2322309C Quinolin-4-yl derivatives |
| 05/15/2008 | WO2008056452A1 Utilization of rare sugar for slowing the onset or progress of mobility impairment relating to amyotrophic lateral sclerosis |
| 05/15/2008 | US20080114062 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors |
| 05/15/2008 | US20080113965 Skeletal muscle protecting agent |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113916 Povidone-Containing Carriers for Polypeptide Growth Factors |
| 05/15/2008 | US20080113049 Compositions and methods for uterine relaxing |